Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOBOCERTINIB vs MOLNUPIRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOBOCERTINIB vs MOLNUPIRAVIR: Safety Overview

Metric MOBOCERTINIB MOLNUPIRAVIR
Total FAERS Reports 715 4,788
Deaths Reported 320 424
Death Rate 44.8% 8.9%
Hospitalizations 227 802
Average Patient Age 65.7 yrs 71.1 yrs
% Female Patients 66.1% 54.9%
FDA Approval Date Sep 15, 2021 N/A
Manufacturer N/A Merck Sharp & Dohme LLC
Route N/A ORAL
Marketing Status Discontinued N/A